{
    "Trade/Device Name(s)": [
        "Aperio GT 450 DX"
    ],
    "Submitter Information": "Leica Biosystems Imaging, Inc.",
    "510(k) Number": "K232202",
    "Predicate Device Reference 510(k) Number(s)": [
        "K190332"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "PSY"
    ],
    "Summary Letter Date": "July 25, 2023",
    "Summary Letter Received Date": "July 25, 2023",
    "Submission Date": "April 16, 2024",
    "Regulation Number(s)": [
        "21 CFR 864.3700"
    ],
    "Regulation Name(s)": [
        "Whole slide imaging system"
    ],
    "Analyte Class(es)": [
        "anatomic pathology"
    ],
    "Analyte(s)": [],
    "Specimen Type(s)": [
        "Formalin-fixed paraffin-embedded (FFPE) tissue"
    ],
    "Specimen Container(s)": [
        "Glass slide"
    ],
    "Instrument(s)/Platform(s)": [
        "Aperio GT 450 DX scanner",
        "Aperio WebViewer DX",
        "Barco MDPC-8127",
        "Dell UP3017",
        "Dell U3023E",
        "Dell U3223QE",
        "Sectra Digital Pathology Module (3.3)"
    ],
    "Method(s)/Technology(ies)": [
        "Whole slide imaging",
        "Brightfield scanning",
        "Digital image creation"
    ],
    "Methodologies": [
        "Digital pathology",
        "Image acquisition",
        "Image viewing"
    ],
    "Submission Type(s)": [
        "System",
        "Scanner",
        "Viewer",
        "Software",
        "Component"
    ],
    "Document Summary": "FDA 510(k) summary for Aperio GT 450 DX whole slide imaging system for digital acquisition and review of pathology slides from FFPE tissue.",
    "Indications for Use Summary": "Intended for in vitro diagnostic use as an aid to the pathologist for reviewing and interpreting digital images of surgical pathology slides prepared from FFPE tissue, for creation and viewing of digital images of scanned glass slides appropriate for manual visualization by light microscopy.",
    "fda_folder": "Pathology"
}